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Edited by Judit Ova´diAbstract Acetohydroxyacid synthase (AHAS) is a thiamin
diphosphate- (ThDP-) and FAD-dependent enzyme that cata-
lyzes the ﬁrst common step in the biosynthetic pathway of the
branched-amino acids such as leucine, isoleucine, and valine.
The genes of AHAS from Mycobacterium tuberculosis were
cloned, and overexpressed in E. coli and puriﬁed to homogeneity.
The puriﬁed AHAS from M. tuberculosis is eﬀectively inhibited
by pyrazosulfuron ethyl (PSE), an inhibitor of plant AHAS en-
zyme, with the IC50 (inhibitory concentration 50%) of 0.87 lM.
The kinetic parameters of M. tuberculosis AHAS were deter-
mined, and an enzyme activity assay system using 96-well micro-
plate was designed. After screening of a chemical library
composed of 5600 compounds using the assay system, a new class
of AHAS inhibitor was identiﬁed with the IC50 in the range of
1.8–2.6 lM. One of the identiﬁed compounds (KHG20612) fur-
ther showed growth inhibition activity against various strains of
M. tuberculosis. The correlation of the inhibitory activity of the
identiﬁed compound against AHAS to the cell growth inhibition
activity suggested that AHAS might be served as a target protein
for the development of novel anti-tuberculosis therapeutics.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Inhibitor screening; Antimycobacterial activity1. Introduction
The branched-chain amino acids such as leucine, isoleucine
and valine belong to essential amino acids and are synthesized
by many microbes and plants by various biosynthetic enzymes.
Acetohydroxyacid synthase (AHAS; EC 2.2.1.6) is one of the
anabolic enzymes that catalyze the ﬁrst step in the biosynthesis
of branched-chain amino acids [1,2]. In plants and microbes,
AHAS is an essential enzyme, and speciﬁc inhibitors of plant
AHAS can be used as herbicides [3,4]. AHAS consists of two
subunits, the larger catalytic subunit and the smaller regula-
tory subunit. The catalytic subunit has a highly conserved thi-
amin diphosphate (ThDP) binding site and Mg2+ is required*Corresponding author. Fax: +82 2 2299 0762.
E-mail address: myyoon@hanyang.ac.kr (M.-Y. Yoon).
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doi:10.1016/j.febslet.2005.07.055for anchoring the diphosphate moiety of ThDP in the active
site [5]. The catalytic subunit of AHAS has one molecule of
FAD per active site [5]. Although the catalytic mechanism
involves no redox reaction, binding of FAD is essential for
the catalytic activity [2]. It is proposed that FAD contributes
to the maintenance of structural integrity [2] or it protects
the reaction intermediate in the catalytic cycle [6].
Mycobacterium tuberculosis is the pathogen of tuberculosis
which remains a major threat to the human population, being
responsible for 2–3 millions deaths every year worldwide [7].
Due to the emergence of multi-drug resistant strains of M.
tuberculosis, there is a need to develop new drug target proteins
of M. tuberculosis. Recently, it has been shown that branched
amino acids auxotrophic strain of mycobacterium failed to
proliferate because of the inability to use amino acids from
their hosts [8], indicating that inhibitors for the branched-chain
amino acid biosynthesis could be used as anti-mycobacterium
agents [9]. These observations suggested that AHAS could be a
potential target of new anti-TB drugs. It is notable that the
recombinant AHAS from Mycobacterium avium, which is
another human TB pathogens, was eﬃciently inhibited by sul-
fonylureas [10], herbicide that inhibits plant AHAS.
In this report, we have cloned, expressed, puriﬁed and char-
acterized the catalytic and regulatory subunits of AHAS from
M. tuberculosis for the ﬁrst time. Moreover, a microplate-
based enzyme assay was developed to screen small molecules
as an inhibitor of catalytic subunits of AHAS from the chem-
ical library. A new class of AHAS inhibitor was identiﬁed, and
its antimycobacterial activity was determined.2. Materials and methods
2.1. Materials
The genomic DNA of M. tuberculosis H37Rv was obtained from
Korean Institute of Tuberculosis (Seoul, Korea). Sodium pyruvate,
FAD, ThDP (named as cocarboxylase), branched-chain amino acids,
creatine and a-naphtol were purchased from Sigma (St. Louis,
USA). Bacto-tryptone, yeast extract and bacto-agar were obtained
from Difco Laboratories (Sparks, USA). Restriction endonuclease
and other molecular biology enzymes were purchased from New Eng-
land BioLabs (Beverly, USA). The herbicides were obtained from Kor-
ea Research Institute of Chemical Technology (Daejeon, Korea). The
chemical library containing 5600 synthetic compounds was obtained
from Korea Institute of Science and Technology (Seoul, Korea). All
other materials were of analytical grade.ation of European Biochemical Societies.
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The DNA fragments encoding the open reading frames of the
small (TIGR locus NT02MT3271) and the large (TIGR locus
NT02MT3272) subunits of AHAS from the M. tuberculosis H37Rv
strain were ampliﬁed by PCR using gene speciﬁc primers which have
restriction sites of NdeI and HindIII. The ampliﬁed DNAs were in-
serted into the NdeI/HindIII sites of pET28a (Novagen, Madison,
USA) producing fusion proteins with N-terminal hexahistidine tags.
The resulting expression vectors for the catalytic and regulatory sub-
units were referred to as pMHB and pMHN.2.3. Expression and puriﬁcation of recombinant AHAS
The expression plasmids (pMHB and pMHN) were transformed
into Escherichia coli BL21(DE3). Transformed bacteria were grown
at 37 C in LB medium containing 50 lg/ml of kanamycin until optical
density of the culture at 600 nm reached 0.7–0.8. Expression of recom-
binant AHAS of M. tuberculosis was induced by addition of 0.5 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) and additional incuba-
tion for overnight at 18 C.
The E. coli cells expressing the catalytic subunit of AHAS were har-
vested by centrifugation at 3000 · g for 15 min at 4 C. For the lysis,
cells were resuspended in buﬀer-A (20 mM sodium phosphate, pH
8.0, 0.5 M NaCl and 20 mM imidazole) containing 1% (v/v) Triton
X-100 and protease inhibitor cocktail (Roche, Indianapolis, USA),
and disrupted by two successive passages through a French press cell
at 16000 psi and sonication. The crude cell extract was centrifuged
at 23000 · g at 4 C for 30 min, and the supernatant was loaded onto
a Ni2+-charged HiTrap chelating HP column (Amersham, Piscataway,
USA) pre-equilibrated with buﬀer-A. After the column was washed
thoroughly with the same buﬀer, the bound proteins were eluted by
applying a linear gradient of 20–500 mM imidazole in buﬀer-A. Frac-
tions containing the expressed protein were concentrated and dialyzed
against 0.1 M Tris–HCl, pH 7.8 containing 5 mM EDTA, 1 mM dithi-
othreitol (DTT) and 20% (v/v) glycerol, and then stored at 80 C un-
til used. The puriﬁcation procedure of the regulatory subunit of AHAS
was the same as described above except to the inclusion of 0.1% (v/v)
Tween-20 in the column equilibration buﬀer and the gradient of 20–
500 mM imidazole used in Ni2+-charged HiTrap chelating HP column.
For the puriﬁcation of holoenzyme, the mixture of cell pastes express-
ing each of the subunits was resuspended in buﬀer-A, and was followed
by puriﬁcation with Ni2+-charged HiTrap chelating column. The pro-
tein concentration for all samples was determined by Bradford assay
following the instruction manual of the Bradford reagent (Bio-Rad,
Hercules, USA).2.4. Size exclusion chromatography
Size exclusion chromatography was performed on a Superdex 200
HB 10/30 column (Amersham, Piscataway, USA) pre-equilibrated with
100 mM potassium phosphate, pH 7.5 containing 0.15 M NaCl and
1 mM DTT at a ﬂow rate of 0.5 ml/min. A sample of 100 ll (0.6–
2.2 mg/ml) was loaded on the column. Elution of proteins was moni-
tored by absorbance at 280 nm using the ACTA Puriﬁer System
(Amersham, Piscataway, USA).Fig. 1. SDS–PAGE analysis of proteins obtained by expression of
pMHB and pMHN plasmids. Electrophoresis was performed using a
12% polyacrylamide gel and the proteins were stained with Coomassie
blue R-250. Lane M, protein marker; lane 1, un-induced BL21 (DE3);
lane 2, induced BL21 (DE3) containing pMHB plasmid; lane 3,
induced BL21 (DE3) containing pMHN plasmid; lane 4, puriﬁed large
subunit; lane 5, puriﬁed small subunit; lane 6, puriﬁed holoenzyme.2.5. Microplate assay for AHAS activity
The AHAS activity was measured according to the method of Singh
et al. [11] with the following modiﬁcations. All chemicals in the library
were dissolved in dimethyl sulfoxide (DMSO) at a concentration of
2 mM. Four microliters of chemical solution (ﬁnal 40 lM) was added
to individual wells of the 96-well microplate containing 156 ll of reac-
tion buﬀer (ﬁnal concentration of 100 mM potassium phosphate, pH
7.5, 1 mM ThDP, 10 mM MgCl2, 50 lM FAD, and 0.5 lg large sub-
unit at 200 ll reaction mixture), and the mixture was pre-incubated
at 37 C for 10 min. Reactions were initiated by adding 40 ll of
375 mM pyruvate (ﬁnal 75 mM). After incubation at 37 C for 1 h,
the reaction was terminated by the addition of 30 ll of 4 M H2SO4.
The reaction mixture was further incubated at 65 C for 15 min to
decarboxylate the reaction product, acetolactate. Then 100 ll of reac-
tion product was mixed with 90 ll of 0.5% (w/v) creatine and 90 ll of
5% (w/v) a-naphtol solution in 2.5 M NaOH (freshly prepared), and
incubated at 65 C for 15 min. The absorbance of the red-colored com-
plex of unknown structure (e = 20000 M1 cm1) was measured at
525 nm using a Spectra Max 340 spectrophotometer (MolecularDevices, Sunnyvale, USA). One unit (U) of activity is deﬁned as the
amount of enzyme that is required for the production of 1 lmol of
acetolactate per minute under the assay conditions described above.
2.6. Measurement of antimycobacterial activity
The inhibitory activity of the selected compound on the growth of
M. tuberculosis was measured as described previously [12]. Ten isolates
of M. tuberculosis were randomly selected from the drug susceptibility
tests (DST) using by Lowenstein–Jensen medium. DST for anti-TB
drugs was done by the method of absolute concentration [12]. The
drug concentrations for susceptibility testing were 0.2 lg/ml and
40 lg/ml for isoniazid and rifampicin, respectively.3. Results
3.1. Expression and puriﬁcation
The coding sequences of ilvB (catalytic subunit) and ilvN
(regulatory subunit) from M. tuberculosis H37Rv strain were
cloned into the pET28a (+) expression vector. The expression
level of endogenous AHAS in E. coli BL21(DE3) is negligible
compared to the overexpressed recombinant AHAS [13]. Both
of the catalytic and regulatory subunits were expressed as N-
terminal hexahistidine-tagged fusion proteins. The solubility
of the expressed proteins was very low, and most of the ex-
pressed protein was recovered as inclusion bodies when the
cells were grown at 37 C. However, the solubility of the pro-
teins was signiﬁcantly increased at the growth temperature of
18 C. Each subunit of AHAS enzyme was puriﬁed using hexa-
histidine aﬃnity chromatography. The molecular weights of
the catalytic and regulatory subunits of AHAS were measured
as 68.3 and 20.4 kDa in SDS–PAGE, respectively, which were
well matched with the calculated values (Fig. 1). The maximum
solubility of the catalytic subunit was about 10 mg/ml. How-
ever, the solubility of the regulatory subunit was much lower,
and it became aggregated at concentrations higher than
0.5–0.7 mg/ml. The holoenzyme of AHAS was puriﬁed from
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molar ratio of the catalytic and regulatory subunits in the puri-
ﬁed holoenzyme fraction was 1:1 based on the intensity of the
protein bands in SDS–PAGE (Fig. 1, lane 6).
3.2. Size determination of AHAS large subunit and holoenzyme
The native sizes of AHAS catalytic subunit and holoen-
zyme were measured by size exclusion chromatography. AsFig. 2. Gel ﬁltration chromatography of AHAS large subunit (broken
line) and holoenzyme (full line). This data was measured as described in
Section 2. The arrows indicate the elution volume of standard proteins.
Table 1







M. tuberculosisa 2.8 2.76 ± 0.12 51.23 ± 2.
4.6 1.56 ± 0.39 1.40 ± 0.3
M. aviumb 4 2.0 ± 0.2 7.5 ± 0.4
E. coliIc 0.12 25
0.40 3.7
E. coliIId 20 5.0 ± 0.5 0.65 ± 0.0
E. coliIIIe 0.37 86 ± 14 29 ± 7
2.6 11.5 ± 1.4 18 ± 3
S. cerevisiaef 6.8 ± 0.7 8.6 ± 1.4 110g
49.0 ± 1.8 18.1 ± 1.3
A. thalianah 7.88 8.01 ± 0.66 25.3 ± 1.4
11.7 ± 0.6i
N. tabacumj 2.8–3.4 8.1–12.8 80–210
aIn this study.
bData taken from [10].
cData taken from [20].
dData taken from [21].
eData taken from [14].
fData taken from [16].
gData taken from [22].
hData taken from [13].
iData taken from [15].
jData taken from [23].
kC and H indicate catalytic subunit and holoenzyme, respectively.shown in Fig. 2, the large subunit of AHAS eluted as a sin-
gle peak at nearly the same size such as BSA (molecular
weight, 66 kDa). Under the same conditions, the holoen-
zymes also eluted earlier than alcohol dehydrogenase (molec-
ular weight, 150 kDa) as a single peak, and the size was
estimated to be larger than 300 kDa. These results indicated
that the catalytic subunit of AHAS is a monomer. In con-
trast, the holoenzyme showed a much higher oligomeric
state than the tetrameric complex consisting of two catalytic
and two regulatory subunits as observed in E. coli AHAS
isozyme III [14].
3.3. Kinetic properties
The enzyme activities of the catalytic subunit and holoenzyme
of AHAS were examined using a discontinuous colorimetric as-
say described in Section 2. In the standard assay condition, the
enzyme reaction of 1 h belongs to the period of time that the
concentration of product increased linearly with time (data
not shown). The speciﬁc activities of the catalytic subunit
(7.3 pmole) and holoenzyme (3.4 pmole) were measured as 2.8
and 4.6 U/mg, respectively, indicating that the catalytic subunit
of AHAS was active alone although the holoenzyme was more
active than the catalytic subunit. The speciﬁc activity of the cat-
alytic subunit at pH 6.0–8.0 was similar to that of the holoen-
zyme, with a pH optimum of 7.0. The activity of the enzymes
at pH 6.0 was only reduced to about 6.4% compared with the
activity at pH 7.0 (data not shown). Kinetic parameters of the
catalytic subunit and holoenzyme of AHAS regarding to
the substrate and cofactors were measured by ﬁt to the follow-








3 270 ± 20.8 C
16.3 ± 1.73 H
0.1 56 ± 5 H
760 C
H
3 0.01 ± 0.002 0.17 ± 0.04 H
3100 ± 900 C
3300 ± 800 2.2 ± 0.5 12.7 ± 0.14 H
280g 0.3g C
0.16 ± 0.02 H
198 ± 19 1.46 ± 0.22 C
0.23 ± 0.07i H
1.4–2.6 C
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where m is the initial rate, Vmax is the maximal rate, Km is the
Michaelis constant, S is substrate concentration and n is Hill
coeﬃcient. Previous reports conﬁrmed that the AHAS enzyme
does not follow Michaelis–Menten kinetics [2]. The saturation
curve of pyruvate for the catalytic subunit and holoenzyme of
M. tuberculosis also does not follow Michaelis–Menten kinet-
ics. The large subunit showed positive cooperativity toward
the substrate (Hill coeﬃcient of 2.0). However, the cooperativ-
ity of the holoenzyme signiﬁcantly decreased (Hill coeﬃcient
of 0.6). Fig. 3 shows a reconstitution curve carried out with
a titration of the regulatory subunit to the catalytic subunit
(3.4 pmole). As the concentration of the regulatory subunit in-
creased, the speciﬁc activity of the catalytic subunit increased
and reached to a maximum speciﬁc activity of 4.6 U/mg, which
is almost the same value as that of holoenzyme which used the
same amount as a large subunit (Table 1).
3.4. Inhibition of M. tuberculosis AHAS by branched-amino
acids and herbicides
The activity of AHAS enzymes from plant and yeast was
feedback regulated by branched-amino acids [15,16] and spe-
ciﬁcally inhibited by herbicides such as sulfonylureas and imi-
dazolinones [3,4,13]. To search for eﬃcient inhibitors against
M. tuberculosis AHAS, the inhibitory activity of branched-
amino acids and various herbicides, which were known to
inhibit plant AHAS, were tested against the holoenzyme and
catalytic subunit of M. tuberculosis AHAS, respectively.
When the activity of AHAS holoenzyme from M. tuberculo-
sis was measured at diﬀerent pyruvate concentrations, it was
partially inhibited by valine, and the inhibition reached satura-
tion at 35–45% depending on the pyruvate concentration. TheFig. 3. Activation of AHAS large subunit activity by addition of small
subunit. Mixtures containing 0.23 lg (3.4 pmole) of large subunit and
various concentrations of small subunit in 100 mM potassium phos-
phate buﬀer, pH 7.5 were pre-incubated at 37 C for 15 min. Reactions
were initiated by the addition of reaction mixture (100 mM pyruvate,
1 mM ThDP, 10 mM MgCl2 and 50 lM FAD in 100 mM potassium
phosphate, pH 7.5). The line represents a curve which was drawn using
the Origin software by the nonlinear regression ﬁtting of hyperbola
equation to the data points.apparent Ki for valine on the pyruvate concentration of 80, 40
and 20 mM are 15.2, 9.4 and 4.7 lM, respectively (Fig. 4A).
The inhibitory activities of isoleucine and leucine were further
examined along with valine at 100 mM of pyruvate. Leucine
failed to show any signiﬁcant inhibition on the AHAS holoen-
zyme ofM. tuberculosis, and isoleucine showed inhibition with
much less degree than valine (Fig. 4B). The apparent Ki for va-
line at 100 mM of pyruvate was calculated as 16.3 lM.
Sulfonylureas (SU) and imidazolinones (IM) were known to
eﬃciently inhibit the AHAS enzyme from bacteria, yeast and
plants [17,18,13]. SU and IM derivatives (Fig. 5) were testedFig. 4. Feedback inhibition by the branched-chain amino acids. (A)
Relative activity of holoenzyme (0.3 lg) in the presence of 80 mM (n),
40 mM (d) and 20 mM (m) pyruvate and various concentrations of
valine amino acid. The lines represents a curve which was drawn using
the Origin software by the nonlinear regression ﬁtting of partial
inhibition: V = Vf + (V0  Vf) Æ Ki/[Valine] + Ki where V0 is the reac-
tion rate without valine, Vf is the reaction rate at maximal inhibition
and Ki is the dissociation constant of the enzyme–valine complex. (B)
Relative activity of holoenzyme (0.3 lg) in the presence of 100 mM
pyruvate and various concentrations of branched-chain amino acid,
valine (n), leucine (d) and isoleucine (m).
Fig. 5. Chemical structure of sulfonylurea (SU) and imidazolinone (IM) herbicides tested in this study. The % inhibition values of M. tuberculosis
AHAS catalytic subunit were determined as described under Section 2 using 40 lM of herbicides. The calculated values are: PSE (92%); PSM (89%);
SMM (89%); MSM (89%); CE (85%); TS (70%); NS (64%); others (<10%).
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M. tuberculosis AHAS. Among 15 tested compounds, only
pyrazosulfuron ethyl (PSE), promisulfuron methyl (PSM), sul-
fometuron methyl (SMM), metsulfuron methyl (MSM), and
chlorimuron ethyl (CE) inhibited more than 80% of the activ-
ity at 40 lM (Fig. 5), and the dose-dependent inhibition curve
of the ﬁve compounds were measured (Fig. 6A). On the con-
trary, triasulfuron (TS) and nicosulfuron (NS) were weakly
inhibited to less than 70% at 40 lM, and imidazoline deriva-
tives showed no inhibitory activity.
3.5. Screening of AHAS inhibitors
To identify small molecule inhibitors against theM. tubercu-
losis AHAS, a discontinuous colorimetric assay method, which
is suitable for high throughput screening (HTS) of AHAS, was
performed for screening of a chemical library of 5600 com-
pounds. After the screening of the library, we identiﬁed four
structurally related hit compounds that inhibited the enzyme
activity of the catalytic subunit by more than 90% at the con-
centration of 40 lM. The structure of hit compounds
(KHG20612, KHG20614, KHG20613, and KHG20616),
which were characterized by the disulﬁde bond containing phe-
nyl and 1-substituted triazolyl derivative, are shown in Fig. 7.Four of the tested compounds inhibited the catalytic subunit
AHAS of M. tuberculosis by the dose-dependent inhibition
having the IC50 values in the range of 1.8–2.6 lM (Fig. 6B).
These novel compounds acts as a potent inhibitor of the M.
tuberculosis AHAS with the same eﬃciency as the previously
tested AHAS herbicides.
3.6. Inhibition kinetics and antimycobacterial activity of
KHG20612
Among these hit compounds, KHG20612 was selected as a
representative structure and was further analyzed to explore
its inhibition mechanism. The eﬀect of KHG20612 on the ini-
tial rate is illustrated in Fig. 8. This compound is a non-com-
petitive inhibitor for catalytic subunit of M. tuberculosis
AHAS and the values of Kis and Kii were determined by ﬁtting
Eq. (2) to the data.
m ¼ V max=f1þ ½I =K ii þ ðKm=½AÞð1þ ½I =K isÞg ð2Þ
KHG20612 compound was further tested for their ability to
inhibit the growth of M. tuberculosis. A total of 10 strains of
M. tuberculosis isolated from Korean patients were tested.
Half of them were resistant to isoniazid and rifampicin
(MDR) and the other half was susceptible to all anti-TB drugs
Fig. 6. The relative activity of the AHAS large subunit (0.3 lg) as
function of the concentration of several herbicides (A) and several hit
compounds (B). The activity was measured as described in Section 2
and the lines were drawn using the Origin software. The IC50 are: (A)
PSE (0.87 lM); PSM (4.19 lM); SMM (4.79 lM); MSM (5.96 lM);
CE (8.97 lM); (B) KHG20612 (1.77 lM); KHG20614 (1.99 lM);
KHG20613 (2.33 lM); KHG20616 (2.55 lM).
Fig. 7. Chemical structure of hit compounds obtain
Fig. 8. Inhibition of catalytic subunits of M. tuberculosis AHAS by
new inhibitor, KHG20612. Initial rates were measured as a function of
the concentration of pyruvate at ﬁxed inhibitor concentration of 0 (.),
3.75 (m), 4.4 (d) and 5 (n) lM. The data were ﬁtted to Eq. (2), and
inhibition constants were determined to be: Kis = 0.43 ± 0.16 lM,
Kii = 1.03 ± 0.36 lM.
4908 K.-J. Choi et al. / FEBS Letters 579 (2005) 4903–4910(allS). KHG20612 showed inhibitory activity against
more than half of the tested isolates at higher than 20 lg/ml
(Table 2).4. Discussion
In this study, the AHAS of M. tuberculosis was expressed in
E. coli, puriﬁed to homogeneity and examined for its kinetic
parameters. Analysis of the genomic sequence ofM. tuberculo-
sis showed that four genes (ilvB, ilvB2, ilvG and ilvX) have se-
quence homology to the catalytic subunits of AHAS and one
gene (ilvN) to the regulatory subunit. Among these genes, ilvX
and ilvG have highly homology to Mycobacterium laprae and
E. coli AHAS isozyme II. The sequence of ilvB2 was signiﬁ-
cantly diﬀerent from ilvB, ilvG or ilvX, and its function is un-
known as yet. When proteins of ilvB and ilvN genes from
Mycobacterium avium were expressed, they showed AHAS
activity including dependence on the expected cofactors anded from the screening of the chemical library.
Table 2
The antimycobacterial activity of KHG20612 compound against 10 clinical isolates of M. tuberculosis
Control 2 lg/ml 5 lg/ml 20 lg/ml 50 lg/ml 100 lg/ml
1 allS ++++ ++++ ++++ ++++ ++ +
2 MDR ++ ++ ++ + 30 20
3 MDR ++ ++ ++ ++ + +
4 MDR ++ ++ ++ ++ + +
5 allS ++ + ++ + ++ ++ + 30
6 allS ++ + ++ + ++ + ++ ++ +
7 allS ++++ ++++ ++++ ++++ ++++ ++++
8 allS ++++ ++++ ++++ ++++ ++ + +++
9 MDR + + + + 30 20
10 MDR ++ ++ ++ ++ ++ 30
MDR: isoniazid and rifampicin resistant isolates.
allS: all anti-TB drugs susceptible isolates.
The colony counting: +, <100 colony; ++, 100–200; +++, 200–500; ++++, >500.
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genes from M. tuberculosis expressed in this study showed
the enzymatic characteristics of AHAS enzymes in the biosyn-
thetic pathway of branched amino acids. The puriﬁed catalytic
subunit showed slightly reduced enzymatic activity compared
to that of the holoenzyme. The kinetic parameters and speciﬁc
activity of the catalytic subunit and holoenzyme ofM. tubercu-
losis AHAS enzymes were similar to those from the M. avium.
The regulatory subunit appeared to increase the catalytic
activity by binding to the catalytic subunit as observed in
E. coli AHAS I and III [2]. It is proved that the holoenzyme
of AHAS from E. coli AHAS III is heterotetramers composed
of two pairs of catalytic and regulatory subunits [14]. Pang
et al. [5] suggested that the active site of Saccharomyces cerevi-
siae AHAS is located on the interface of two catalytic subunits
and might be shielded by the regulatory subunit during catal-
ysis. In the case ofM. tuberculosis AHAS, the catalytic subunit
is considered to have an independent active site which is stable
even in the absence of small subunit since the active catalytic
subunit was observed as a monomer in size exclusion chroma-
tography. For the E. coli AHAS III, catalytic subunit was ob-
served to migrate as monomers in the gel ﬁltration, and
Vyazmensky et al. [14] proposed that E. coli AHAS III cata-
lytic subunit may dimerise to a small extent that is not detected
in gel ﬁltration chromatography. The observed native size of
the AHAS holoenzyme from M. tuberculosis appeared to be
larger than the calculated size of the heterotetrameric form.
Since the two subunits form the holoenzyme in an equal ratio,
it is assumed that the tetrameric form of holoenzyme is further
oligomerized under experimental conditions. The regulatory
subunit is presumed to play a role in the oligomerization since
it has high propensity for aggregation.
The well-known class of herbicides sulfonylureas inhibited
the biosynthesis of branched-amino acid in both bacteria and
higher plants. The possible application of these compounds
as antibiotics has been speculated since the infected bacteria
could uptake amino acids from their host although these com-
pounds blocked the biosynthetic pathway of infected bacteria.
However, reduced infectivity of the leucine auxotrophic strains
of Mycobacterium bovis (BCG) in mice [19] suggested that the
biosynthetic pathway of branched-amino acids provides novel
targets for the development of antibiotics, especially for the
anti-tuberculosis agents. The recombinant M. tuberculosis
AHAS large subunit was sensitive to sulfonylurea derivatives.
However, M. tuberculosis enzyme showed quite diﬀerent sensi-
tivity to the tested compounds, especially imidazolinones, com-pared to the AHAS enzyme from other organism such as
Arabidopsis thaliana [13], E. coli AHAS II [17] and S. cerevisiae
[18], which are inhibited by imidazolinones. These results indi-
cated that the active site ofM. tuberculosis is probably diﬀerent
from the previously characterized AHAS enzymes from plants,
yeast or E. coli. Sulfonylureas herbicides consist of the sulfonyl
group with the two rings. Additional CH2 group in the sulfo-
nylurea of bensulfuron methyl (BSM) decreased the inhibition
eﬀect of the M. tuberculosis AHAS. From the analysis of the
structure for active sulfonylureas herbicides, 1-substituted
group in the benzene ring has a critical eﬀect on inhibition
of the M. tuberculosis AHAS.
The newly identiﬁed compounds from the screening of the
chemical library eﬃciently inhibited the activity of M. tubercu-
losis enzyme and showed completely diﬀerent structural fea-
tures than sulfonylurea or imidazolinones. One of them
(KHG20612) also showed inhibitory activity against the
growth of several strains of M. tuberculosis, which includes
drug resistant as well as susceptible strains. The screening
method of the inhibitors against the AHAS enzyme form M.
tuberculosis and the utilization of newly identiﬁed inhibitory
compounds would contribute to the development of more po-
tent and novel anti-TB agents.References
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